Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophilic esophagitis: pathogenesis, genetics, and therapy.

Carine Blanchard1, Ning Wang, Marc E Rothenberg

  • 1Division of Allergy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

The Journal of Allergy and Clinical Immunology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intradermal delivery of lipophilic siRNAs enables prolonged skin retention and sustained gene silencing in a porcine model.

Nature communications·2026
Same author

Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findings.

Gut·2026
Same author

Amniotic fluid modifies esophageal epithelium differentiation and inflammatory responses.

American journal of physiology. Gastrointestinal and liver physiology·2024
Same author

Induction of sustained remission and reversal of pathologic transcriptome achieved with tezepelumab in an adolescent with eosinophilic esophagitis.

The journal of allergy and clinical immunology. In practice·2024
Same author

T<sub>H</sub>2 cell compensatory effect following benralizumab treatment for eosinophilic gastritis.

The Journal of allergy and clinical immunology·2024
Same author

Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis.

The Journal of allergy and clinical immunology·2024

Eosinophilic esophagitis (EE) is a distinct esophageal disorder. Research shows it involves multiple genes, including eotaxin-3, enabling targeted therapies.

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Eosinophilic esophagitis (EE) is a newly identified condition involving eosinophil buildup in the esophagus.
  • EE symptoms often resemble gastroesophageal reflux disease (GERD), but they differ significantly in tissue characteristics and treatment response.

Purpose of the Study:

  • To molecularly distinguish EE from other esophagitis types.
  • To explore targeted therapeutic interventions for EE.

Main Methods:

  • Analysis of genetic factors contributing to EE.
  • Investigation of the role of eotaxin-3 in EE pathogenesis.

Main Results:

  • EE is characterized by the interplay of multiple genes.

Related Experiment Videos

  • Eosinophil chemoattractant eotaxin-3 plays a significant role in EE.

    • Conclusions:

    • EE can be molecularly differentiated from other forms of esophagitis.
    • Understanding the genetic basis of EE, particularly eotaxin-3, opens avenues for targeted therapies.